Cargando…
Downregulation of DOCK1 sensitizes bladder cancer cells to cisplatin through preventing epithelial–mesenchymal transition
During the past several decades, resistance to single or multiple anticancer agents has posed a great challenge in cancer therapy. Dedicator of cytokinesis 1 (DOCK1), the first identified member in DOCK family, plays diverse roles in cellular processes, including tumorigenesis. In this study, we exp...
Autores principales: | Chen, Da-jin, Chen, Wei, Jiang, Hong, Yang, Hao, Wang, Yu-cheng, Chen, Jiang-hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019270/ https://www.ncbi.nlm.nih.gov/pubmed/27660415 http://dx.doi.org/10.2147/DDDT.S101998 |
Ejemplares similares
-
Shikonin suppresses the epithelial-to-mesenchymal transition by downregulating NHE1 in bladder cancer cells
por: Mo, Lijun, et al.
Publicado: (2021) -
Klotho prevents epithelial–mesenchymal transition through Egr-1 downregulation in diabetic kidney disease
por: Li, Yang, et al.
Publicado: (2021) -
EOFAZ inhibits endothelial-to-mesenchymal transition through downregulation of KLF4
por: Zhang, Yanyan, et al.
Publicado: (2020) -
Autophagy inhibition impairs the epithelial-mesenchymal transition and enhances cisplatin sensitivity in nasopharyngeal carcinoma
por: Su, Zhongwu, et al.
Publicado: (2017) -
Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Lung Cancer Cells and Inhibits Regulating Epithelial-to-Mesenchymal Transition
por: Liu, Shenggang, et al.
Publicado: (2016)